{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T05:52:46Z","timestamp":1693115566749},"reference-count":47,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2020,8,31]]},"DOI":"10.5582\/ddt.2020.03058","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T22:06:29Z","timestamp":1598652389000},"page":"197-203","source":"Crossref","is-referenced-by-count":4,"title":["MicroRNA analysis of NCI-60 human cancer cells indicates that miR-720 and miR-887 are potential therapeutic biomarkers for breast cancer"],"prefix":"10.5582","volume":"14","author":[{"given":"Zhiyuan","family":"Lv","sequence":"first","affiliation":[{"name":"School of Basic Medicine, Qingdao University, Qingdao, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Qingdao University, Qingdao, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wandong","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Qingdao University, Qingdao, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"He","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Qingdao University, Qingdao, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ambros V. The functions of animal microRNAs. Nature. 2004; 431:350-355.","DOI":"10.1038\/nature02871"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kwak PB, Iwasaki S, Tomari Y. The microRNA pathway and cancer. Cancer Sci. 2010; 101:2309-2315.","DOI":"10.1111\/j.1349-7006.2010.01683.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Singh NK. microRNAs Databases: Developmental Methodologies, Structural and Functional Annotations. Interdiscip Sci. 2017; 9:357-377.","DOI":"10.1007\/s12539-016-0166-7"},{"key":"4","unstructured":"4. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 2007; 96 (Suppl):R40-44."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lu J, Getz G, Miska EA, Alvarezsaavedra E, Lamb J, Peck D, Sweetcordero A, Ebert BL, Mak RH, Ferrando AA. MicroRNA expression profiles classify human cancers. Nature. 2005; 435:834-838.","DOI":"10.1038\/nature03702"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wang Y, Lee CG. MicroRNA and cancer--focus on apoptosis. J Cell Mol Med. 2010; 13:12-23.","DOI":"10.1111\/j.1582-4934.2008.00510.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wu W, Sun M, Zou GM, Chen J. MicroRNA and cancer: Current status and prospective. Int J Cancer. 2010; 120:953-960.","DOI":"10.1002\/ijc.22454"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kohnehrouz BB, Bastami M, Nayeri S. <i>In silico<\/i> identification of novel microRNAs and targets using EST analysis in allium cepa L. Interdiscip Sci. 2018; 10:771-780.","DOI":"10.1007\/s12539-017-0240-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Volinia S, Calin GA, Liu CG, <i>et al.<\/i> A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103:2257-2261.","DOI":"10.1073\/pnas.0510565103"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L. MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer. Cancer Res. 2008; 68:10307.","DOI":"10.1158\/0008-5472.CAN-08-1954"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wei J, Gao W, Zhu CJ, Liu YQ, Mei Z, Cheng T, Shu YQ. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer. 2011; 30:407-414.","DOI":"10.5732\/cjc.010.10522"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, Zhuang R, Ning G, Zhang C. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2012; 58:610-618.","DOI":"10.1373\/clinchem.2011.172767"},{"key":"13","unstructured":"13. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR. Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988; 48:4827-4833."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, Weinstein JN. DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther. 2009; 8:713-724.","DOI":"10.1158\/1535-7163.MCT-08-0921"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Weinstein JN. Spotlight on molecular profiling: &quot;Integromic&quot; analysis of the NCI-60 cancer cell lines. Mol Cancer Ther. 2006; 5:2601-2605.","DOI":"10.1158\/1535-7163.MCT-06-0640"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mondal SI, Khadka B, Akter A, Roy PK, Sultana R. Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: an alternative approach by targeting transcriptional activator ToxT. Interdiscip Sci. 2014; 6:108-117.","DOI":"10.1007\/s12539-012-0046-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z, Liu CG, Reinhold W, Lorenzi PL, Kaldjian EP, Croce CM, Weinstein JN, Sadee W. MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther. 2007; 6:1483-1491.","DOI":"10.1158\/1535-7163.MCT-07-0009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, Chary KK, Reimers MA, Scherf U, Kahn A, Dolginow D. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther. 2007; 6:820-832.","DOI":"10.1158\/1535-7163.MCT-06-0650"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Liu H, D&apos;Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, Weinstein JN, Pommier Y, Reinhold WC. mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther. 2010; 9:1080-1091.","DOI":"10.1158\/1535-7163.MCT-09-0965"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ikediobi ON, Davies H, Bignell G, <i>et al.<\/i> Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther. 2006; 5:2606-2612.","DOI":"10.1158\/1535-7163.MCT-06-0433"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, Munson PJ, Petricoin E, 3rd, Liotta LA, Weinstein JN. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A. 2003; 100:14229-14234.","DOI":"10.1073\/pnas.2331323100"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ehrich M, Turner J, Gibbs P, Lipton L, Giovanneti M, Cantor C, van den Boom D. Cytosine methylation profiling of cancer cell lines. Proc Natl Acad Sci U S A. 2008; 105:4844-4849.","DOI":"10.1073\/pnas.0712251105"},{"key":"23","unstructured":"23. Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT, Bates SE. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharmacol. 1994; 46:627-638."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ma Q, Song J, Chen Z, Li L, Wang B, He N. Identification of potential gene and microRNA biomarkers for colon cancer by an integrated bioinformatical approach. Transl Cancer Res. 2018; 7:17-29.","DOI":"10.21037\/tcr.2017.12.09"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Acharya PP, Khatri HR, Janda S, Zhu J. Synthesis and antitumor activities of aquayamycin and analogues of derhodinosylurdamycin A. Org Biomol Chem. 2019; 17:2691-2704.","DOI":"10.1039\/C9OB00121B"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bhagirath D, Yang TL, Bucay N, Sekhon K, Majid S, Shahryari V, Dahiya R, Tanaka Y, Saini S. MicroRNA-1246 is an exosomal biomarker for aggressive prostate cancer. Cancer Res. 2018; 78:1833-1844.","DOI":"10.1158\/0008-5472.CAN-17-2069"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chand M, Keller DS, Mirnezami R, Bullock M, Bhangu A, Moran B, Tekkis PP, Brown G, Mirnezami A, Berho M. Novel biomarkers for patient stratification in colorectal cancer:A review of definitions,emerging concepts,and data. World J Gastrointest Oncol. 2018; 10:145-158.","DOI":"10.4251\/wjgo.v10.i7.145"},{"key":"28","unstructured":"28. Huang Y, Zhu J, Li W, Zhang Z, Xiong P, Wang H, Zhang J. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer. Oncol Rep. 2018; 39:1338-1346."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gao X, Wu Y, Yu W, Li H. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma. Oncotarget. 2016; 7:81670-81679.","DOI":"10.18632\/oncotarget.13164"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Li X, Shi Y, Yin Z, Xue X, Zhou B. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma. J Transl Med. 2014; 12:159.","DOI":"10.1186\/1479-5876-12-159"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Gaur P, Chaturvedi A. Clustering and Candidate Motif Detection in Exosomal miRNAs by Application of Machine Learning Algorithms. Interdiscip Sci. 2017;1-9.","DOI":"10.1007\/s12539-017-0253-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lankapalli AR, Kannabiran K. Interaction of marine Streptomyces compounds with selected cancer drug target proteins by <i>in silico<\/i> molecular docking studies. Interdiscip Sci. 2013; 5:37-44.","DOI":"10.1007\/s12539-013-0146-0"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Singh AK, Misra K. Human papilloma virus 16 E6 protein as a target for curcuminoids, curcumin conjugates and congeners for chemoprevention of oral and cervical cancers. Interdiscip Sci. 2013; 5:112-118.","DOI":"10.1007\/s12539-013-0159-8"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kim N, He N, Kim C, Zhang F, Lu Y, Yu Q, Stemke-Hale K, Greshock J, Wooster R, Yoon S, Mills GB. Systematic analysis of genotype-specific drug responses in cancer. Int J Cancer. 2012; 131:2456-2464.","DOI":"10.1002\/ijc.27529"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Song J, Ma Q, Hu M, Qian D, Wang B, He N. The Inhibition of miR-144-3p on Cell Proliferation and Metastasis by Targeting TOP2A in HCMV-Positive Glioblastoma Cells. Molecules. 2018; 23:3259.","DOI":"10.3390\/molecules23123259"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kim N, Park H, He N, Lee HY, Yoon S. QCanvas: An Advanced Tool for Data Clustering and Visualization of Genomics Data. Genomics Inform. 2012; 10:263-265.","DOI":"10.5808\/GI.2012.10.4.263"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Bhat NS, Colden M, Dar AA, Saini S, Arora P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S, Dahiya R. MicroRNA-720 Regulates E-cadherin-alphaE-catenin Complex and Promotes Renal Cell Carcinoma. Mol Cancer Ther. 2017; 16:2840-2848.","DOI":"10.1158\/1535-7163.MCT-17-0400"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Nonaka R, Miyake Y, Hata T, <i>et al.<\/i> Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer. Int J Oncol. 2015; 47:1097-1102.","DOI":"10.3892\/ijo.2015.3064"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Fite K, Gomez-Cambronero J. Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion. J Biol Chem. 2016; 291:719-730.","DOI":"10.1074\/jbc.M115.686006"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Becher OJ, Millard NE, Modak S, <i>et al.<\/i> A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors. PLoS One. 2017; 12:e0178593.","DOI":"10.1371\/journal.pone.0178593"},{"key":"41","unstructured":"41. Kondapaka SB, Singh SS, Dasmahapatra GP, Sausville EA, Roy KK. Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol Cancer Ther. 2003; 2:1093-1103."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Hideshima T, Catley L, Yasui H, Ishitsuka K, Raje N, Mitsiades C, Podar K, Munshi NC, Chauhan D, Richardson PG. Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces <i>in vitro<\/i> and <i>in vivo<\/i> cytotoxicity in human multiple myeloma cells. Blood. 2006; 107:4053-4062.","DOI":"10.1182\/blood-2005-08-3434"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Li Z, Tan F, DJ L, SM S, CJ T. <i>In vitro<\/i> and <i>in vivo <\/i>inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine. J Natl Cancer Inst. 2010; 102:758-770.","DOI":"10.1093\/jnci\/djq125"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Li Z, Oh DY, Nakamura K, Thiele CJ. Perifosine-induced inhibition of Akt attenuates BDNF\/TrkB-induced chemoresistance in neuroblastoma <i>in vivo<\/i>. Cancer. 2011; 117:5412.","DOI":"10.1002\/cncr.26133"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Momota H, Nerio E, Holland EC. Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas <i>in vivo<\/i>. Cancer Res. 2005; 65:7429-7435.","DOI":"10.1158\/0008-5472.CAN-05-1042"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013; 381:400-412.","DOI":"10.1016\/S0140-6736(12)60643-6"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003; 3:330.","DOI":"10.1038\/nrc1074"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/14\/4\/14_2020.03058\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T03:44:16Z","timestamp":1599882256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/14\/4\/14_2020.03058\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2020.03058","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]}}}